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Abstract
Background: Brucellosis is an important zoonosis caused by the genus Brucella. In addition Brucella
represents potential biological warfare agents due to the high contagious rates for humans and
animals. Therefore, the strain typing epidemiological tool may be crucial for tracing back source of
infection in outbreaks and discriminating naturally occurring outbreaks versus bioterroristic event.
A Multiple Locus Variable-number tandem repeats (VNTR) Analysis (MLVA) assay based on 15
polymorphic markers was previously described. The obtained MLVA band profiles may be resolved
by techniques ranging from low cost manual agarose gels to the more expensive capillary
electrophoresis sequencing. In this paper a rapid, accurate and reproducible system, based on the
Lab on a chip technology was set up for Brucella spp. genotyping.
Results: Seventeen DNA samples of Brucella strains isolated in Sicily, previously genotyped, and
twelve DNA samples, provided by MLVA Brucella VNTR ring trial, were analyzed by MLVA-15 on
Agilent 2100. The DNA fragment sizes produced by Agilent, compared with those expected,
showed discrepancies; therefore, in order to assign the correct alleles to the Agilent DNA
fragment sizes, a conversion table was produced. In order to validate the system twelve unknown
DNA samples were analyzed by this method obtaining a full concordance with the VNTR ring trial
results.
Conclusion:  In this paper we described a rapid and specific detection method for the
characterization of Brucella isolates. The comparison of the MLVA typing data produced by Agilent
system with the data obtained by standard sequencing or ethidium bromide slab gel electrophoresis
showed a general concordance of the results. Therefore this platform represents a fair
compromise among costs, speed and specificity compared to any conventional molecular typing
technique.
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Background
The genus Brucella comprises Gram-negative bacteria that
are the etiological agents of brucellosis, a zoonosis that
represents one of the most important worldwide disease
affecting animals and humans, especially in the Mediter-
ranean areas [1,2]. The disease can be transmitted to
humans directly by contact with infected animals or indi-
rectly by contaminated dairy products. Brucella infections
can cause chronic debilitating diseases in humans with
the involvement of multiple organs and low mortality
while in the domesticated animals can lead to reproduc-
tive failure with subsequent economic loss. Six classically
species are recognized within the genus Brucella: Brucella
abortus (7 biovars), Brucella melitensis (3 biovars), Brucella
suis (5 biovars), Brucella ovis, Brucella canis, and Brucella
neotomae [3]. Isolation and characterization of novel dif-
ferent Brucella strains from a wide variety wildlife species
from terrestrial and marine mammals, recently classified
as three additional species, B. ceti (cetaceans) B. pinnipedi-
alis and B. microti underline the importance of wildlife as
reservoir for zoonotic brucellosis [4,5]. In addition, Bru-
cella spp. represent potential biological warfare agents due
to the high contagious rates for humans and animals
[6,7]. Therefore it is very important to have a strain typing
epidemiological tool for source trace back in outbreaks of
infection. Characterization of Brucella at species and bio-
var level can be performed by differential microbiological
approaches used for phenotyping [8]. However, these bio-
typing methods are time consuming and potentially haz-
ardous for laboratory personnel. In addition, the limited
variation among some species and biovars may result in
conflicting data and complicate interpretation [9,1]. Bio-
typing methods are not therefore suitable for epidemio-
logical tracking where a more accurate identification is
necessary. Thus, genetic characterization using molecular
DNA technology has been investigated and several molec-
ular techniques for subtyping have been proposed. In the
last years PCR-based assays have been employed in an
attempt to find suitable DNA markers for the molecular
typing of Brucella. Examples are repetitive intergenic pal-
indromic sequence-PCR (REP-PCR) [10], random ampli-
fied polymorphic DNA-PCR (RAPD-PCR) [11], arbitrary
primed-PCR (AP-PCR) [12], amplified fragment length
polymorphism (AFLP) [13], single nucleotide polymor-
phism (SNP) [14,15], and polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP)
[16]. Recently, a highly discriminatory typing system
called MLVA, based on multilocus characterization of var-
iable number of tandem repeats (VNTRs), has been pro-
posed for several pathogens such as Haemophilus
influenzae  [17],  Mycobacterium tuberculosis [18],  Bacillus
anthracis and Yersinia pestis [19-21]. The multilocus VNTR
analysis methods (MLVA-15 and -16) were also described
for Brucella genotyping [22,23,6]. The MLVA-15 is based
on 15 polymorphic markers subdivided in two panels: the
panel 1, consisting of 8 minisatellite markers with a good
species identification capability, and the panel 2, consist-
ing of 7 microsatellite markers with higher discriminatory
power. MLVA-15 assay generates multiple band profiles or
fingerprint patterns and represents a useful molecular
approach for Brucella  typing in spite of the high DNA
homology among Brucella  species (90%) [24]. The
obtained MLVA band profiles may be resolved by differ-
ent techniques ranging from low cost manual agarose gels
to the more expensive capillary electrophoresis sequenc-
ing systems. Recently, a rapid and inexpensive method
based on the Lab on a chip technology (Agilent Technol-
ogies) has been proposed. This miniaturized platform for
electrophoresis applications is able to size and quantitate
PCR fragments, and was previously used for studying the
genetic variability of bcIA gene of Bacillus cereus [25] and
for genotyping of Bacillus anthracis and Yersinia pestis [26].
In this paper we evaluate the possibility to use the Agilent
2100 Bioanalyzer equipment for MLVA typing of Brucella
strains using the selected subset of 15 loci proposed by La
Flèche [23]. On that account, we analyzed by Agilent tech-
nology the collection of seventeen human Brucella isolates
whose MLVA fingerprinting profiles were previously
resolved by capillary electrophoresis sequencing system
[27] and results compared, while twelve DNA samples,
provided in 2007 for a MLVA VNTR ring trial, were de novo
genotyped.
Results
In order to set up this method, we analyzed, by MLVA-15
[23] on Agilent 2100 Bioanalyzer, seventeen Brucella
strains previously identified as B. melitensis biovar 3 by
direct sequencing [27]. The 15 VNTR markers amplified
for bacterial genotyping were arranged into three duplex
and nine singleplex PCR reactions. The arrangement of
different loci in the same multiplex was such to avoid
overlapping of VNTR markers size ranges; in this way it
was possible to use a single 12-wells chip (DNA 1000
LabChip Kit) for strain analysis. After PCR amplification 1
μl of each reaction was loaded into the chip and the
amplification product size estimates were obtained by the
Agilent Software. These values showed discrepancies com-
pared with those expected [27], making difficult the allele
assignment directly from rough data. In order to assign
the correct alleles to the Agilent DNA fragment sizes, a
conversion table containing for each locus the expected
size, the range of observed sizes, including arithmetical
average ± standard deviation, and the corresponding
allele was produced (Additional File 1). We could estab-
lish experimentally the variability range for each allele.
Even if we didn't conduct an extensive study on migration,
these ranges were determined considering interchip/intra-
chip variability from the same amplification product or
different amplification of the same strain allele or, for the
same alleles, different strain amplification (data not
shown). The data are considered valuable only if standard
deviation is lower than the 50% of the repeat unit length.BMC Microbiology 2009, 9:66 http://www.biomedcentral.com/1471-2180/9/66
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In this way, we could measure a variation proportionated
to the relative number of nucleotides in each repeat unit.
All the allele measurements satisfied this criterion, allow-
ing the unambiguous assignment of the correct allele to
each observed value (Additional File 1). In order to vali-
date this platform, we analyzed twelve unknown samples
provided by Dr. Falk Melzer for MLVA Brucella 2007 ring
trial [28]. The Agilent 2100 Bioanalyzer MLVA-15 prod-
ucts were separated and DNA fragment sizes were corre-
lated to the alleles by the conversion table. The resulting
fingerprint for each strain was matched against the MLVA
database Brucella test [29], allowing identification of sam-
ples and their genetic relationship with the other database
strains (Table 1). The identified species were compared
with the VNTR ring trial results [28], obtaining a full con-
cordance.
Discussion
The renewed threat of biological weapons and the appear-
ance of zoonotic infections caused by Brucella spp. have
reinforced the need to provide a rapid and specific detec-
tion method for the characterization of Brucella isolates.
In fact, the discrimination between natural outbreaks
and/or intentional release of micro-organism agents may
be of crucial importance in the context of the bioterror-
ism. Brucella strains differentiation in the last years was
obtained by assays based on the analysis of the polymor-
phism of tandemly repeated DNA sequences. This strategy
has proven to be appropriate for pathogenic bacterial spe-
cies typing with a high genetic homogeneity. Recently a
new multilocus VNTR analysis (MLVA-15) method, based
on a subset of fifteen tandem repeat loci, was described
demonstrating high discriminatory power [23]. The dif-
ferent alleles, amplified by standard PCR techniques, can
be analyzed by several electrophoretic techniques that can
be time-consuming as agarose gel, or require high costs
for reagents and instruments as capillary electrophoresis
sequencing. Our attention was addressed on the Agilent
2100 "Lab on a Chip" platform, in order to obtain a more
rapid and inexpensive method of discrimination. The
loading of the fifteen amplification products in a single
chip provides an increased time-reduction (chip run time
is approximately 30 minutes) as compared to assay run on
agarose gels for the same analysed markers. After data col-
lection and analysis, we observed that the size estimated
by the Agilent 2100 Bioanalyzer were shifted by a variable
value (offset) in respect to the real size. Indeed, the esti-
mated sizes were shifted of a variable value (offset) respect
to the real size estimated by sequencing and each offset
showed a variable range. These differences could be due to
the different nature of the gel matrix or to a slightly biased
flanking sequence or repeat unit specific mobility pattern
[21]. These discrepancies between observed and expected
sizes have been overcome creating a correspondence table
which allows for each observed value to assign the
expected size and corresponding allele (Additional File 1).
The comparison of the results obtained by the multilocus
VNTR analysis (MLVA-15) method [23] on the Agilent
2100 "Lab on a Chip" platform showed a good size corre-
lation with nucleotide sequence analysis, confirming the
rapidity and efficiency of this platform respect to standard
sequencing or ethidium bromide slab gel electrophoresis.
Furthermore, the possibility to compare different chip
data in different times made the system suitable for epide-
miological purposes. We consider this system one the
most promising platforms for MLVA-15 typing because
offers a fair compromise among costs, speed and specifi-
city compared to any of the conventional molecular typ-
ing techniques.
Conclusion
In this paper is described a rapid, accurate and reproduci-
ble system for genotyping of Brucella. The method is based
on Multiple Locus Variable Number Tandem Repeats
Table 1: The twelve strains provided for the Ring trial Brucella 2007.
Strainsa Species Biovar Classification according MLVA Database Genotypingb Origin
bru015 B. suis 2 Thomsen (ATCC23445; BCCN R13) Denmark
bru002 B. abortus 1 544 (ATCC 23448; BCCN R4) England
bru011 B. melitensis 2 63/9 (ATTC 23457; BCCN R2) Turkey
bru004 B. abortus 3 Tulya (ATCC 23450; BCCN R6) Uganda
Bru517/bru522 B. canis B. canis Romania/France
bru016 B. suis 3 686 (ATCC 23446; BCCN R14) United States
bru009 B. melitensis 3 Ether (ATCC 23458; BCCN R3) Italia
bru003 B. abortus 2 86/8/59 (ATCC 23449; BCCN R5) England
bru537 B. ovis France (64)
bru022 B. pinnipediae B2/94 (BCCN 94–73) Scotland
bru014 B. suis 1 1330 (ATCC 23444; BCCN R12) United States
bru001 B. melitensis 1 16M (ATTC 23456; BCCN R1) United States
a Strains according to Le Flèche [23]
b MLVA bank for bacterial genotyping [29]BMC Microbiology 2009, 9:66 http://www.biomedcentral.com/1471-2180/9/66
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(VNTR) Analysis (MLVA) assay with 15 markers (MLVA-
15), previously described, and the Agilent 2100 Bioana-
lyzer, for the separation of nucleic acid molecules. The val-
idation of the system was performed reanalyzing
seventeen DNA samples, previously genotyped by tradi-
tional techniques, and twelve DNA provided for a VNTR
ring trials, obtaining a general concordance of the results.
Therefore MLVA typing data produced by Agilent system
represents an alternative to standard sequencing or ethid-
ium bromide slab gel electrophoresis.
Methods
Brucella strains and DNA extraction
In this study, seventeen Brucella strains isolate from Sicil-
ian hospitalized patients with acute brucellosis [27], and
twelve DNA samples, provided by Dr. Falk Melzer for the
Ring trial Brucella 2007, were analysed. DNA was
extracted using proteinase K and sodium dodecyl sulfate
method. Pellets were resuspended in 50 μl of nuclease-
free water. Twenty nanograms of DNA template were used
for PCR amplifications.
VNTR amplification
VNTR amplifications were performed according to Le
Flèche et al [23]. Fifteen sets of primers previously pro-
posed were used: Bruce06, Bruce08, Bruce11, Bruce12,
Bruce42, Bruce43, Bruce45, Bruce55 (panel 1), and
Bruce04, Bruce07, Bruce09, Bruce16, Bruce18, Bruce21
and Bruce30 (panel 2). The 15 markers were arranged into
3 duplex, indicated as multiplex 1a, 2b and 3c respectively
for the loci bruce 43 and bruce 08, bruce 12 and bruce 18
and bruce 11 and bruce 21 and 9 singleplex. Amplifica-
tion reaction mixtures were prepared in 15 μl volumes
using 1U FastStart polymerase Taq (Roche) and contain-
ing 1 ng of DNA, 1× PCR Roche reaction buffer (10 mM
Tris-HCl, 2,5 mM MgCl2, 50 mM KCl pH 8.3), 0.2 mM
dNTPs (Roche) and 0,3 μM of each flanking primer. Ther-
mal cycling, conducted on a Peltier Thermal Cycler DNA
Engine DYAD (MJ Research), was performed as follows:
The optimized protocol was, after an initial heating at
95°C for 5 min, 35 cycles denaturation at 95°C for 30 sec,
annealing at 60°C for 30 sec and extension at 70°C for 60
sec. A final extension was performed at 70°C for 5 min.
MLVA-15 analysis
The amplification products were loaded into chip wells
prepared according to manufacturer recommendations
(DNA 1000 LabChip Kit). Each chip contains 16 wells: 12
for the samples, 3 for gel mix. After gel preparation, each
sample well was loaded with 1 μl of PCR reaction and 5 μl
of internal marker (containing two MW size standards of
15 and 1500 bp). One microliter of DNA ladder was
loaded in the ladder well. Finally, the chip was vortexed
for 60 sec and inserted into Agilent 2100 Bioanalyzer.
During the separation of the fragments, the samples were
analyzed sequentially and electropherograms, virtual gel
images and table data were shown. Amplification product
size estimates were obtained by using the Agilent 2100
Expert Software version B.02.03.SI307 firmware C.01.055
(Agilent Technologies).
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